pharmaceutical testing – Page 3

Poor reproducibility in dissolution testing results for capsules stored under stressed conditions.

Poor reproducibility in dissolution testing results for capsules stored under stressed conditions. Poor reproducibility in dissolution testing results for capsules stored under stressed conditions. Introduction: Dissolution testing is a critical…

Investigating Non-Uniform Dissolution in Enteric-Coated Tablets During Testing

Investigating Non-Uniform Dissolution in Enteric-Coated Tablets During Testing Investigating Non-Uniform Dissolution in Enteric-Coated Tablets During Testing Introduction: The pharmaceutical industry constantly strives to develop effective drug delivery mechanisms, with enteric-coated…

Lack of validated methods for testing capsule coatings.

Lack of validated methods for testing capsule coatings. Lack of validated methods for testing capsule coatings. Introduction: The pharmaceutical industry relies heavily on solid oral dosage forms, particularly capsules, for…

Managing Non-Homogeneity in Dissolution Profiles for Coated Tablets

Managing Non-Homogeneity in Dissolution Profiles for Coated Tablets Managing Non-Homogeneity in Dissolution Profiles for Coated Tablets Introduction: Coated tablets are a widely used solid dosage form in the pharmaceutical industry,…

Poor correlation between in vitro dissolution and stability data.

Poor correlation between in vitro dissolution and stability data. Poor correlation between in vitro dissolution and stability data. Introduction: In the pharmaceutical industry, the correlation between in vitro dissolution and…

Difficulty in validating capsule integrity for long-term storage conditions.

Difficulty in validating capsule integrity for long-term storage conditions. Difficulty in validating capsule integrity for long-term storage conditions. Introduction: In the pharmaceutical industry, ensuring the integrity of capsules over their…

Difficulty in evaluating the stability of multi-particulate capsules.

Difficulty in evaluating the stability of multi-particulate capsules. Difficulty in evaluating the stability of multi-particulate capsules Introduction: In the pharmaceutical industry, ensuring the stability of drug products is crucial for…

Poor reproducibility in swab recovery studies during cleaning validation.

Poor reproducibility in swab recovery studies during cleaning validation. Poor reproducibility in swab recovery studies during cleaning validation. Introduction: Cleaning validation is a critical component of Good Manufacturing Practices (GMP)…

Difficulty in assessing the stability of capsules containing low-dose APIs.

Difficulty in assessing the stability of capsules containing low-dose APIs. Difficulty in assessing the stability of capsules containing low-dose APIs. Introduction: In the pharmaceutical industry, ensuring the stability of drug…

Poor correlation between laboratory and field stability data for capsules.

Poor correlation between laboratory and field stability data for capsules. Poor correlation between laboratory and field stability data for capsules. Introduction: In the pharmaceutical industry, stability testing is a critical…

Poor standardization of in-process quality control procedures.

Poor standardization of in-process quality control procedures. Poor standardization of in-process quality control procedures. Introduction: In the pharmaceutical industry, maintaining the highest quality standards is paramount. This is especially true…

Managing Temperature Fluctuations in Stability Testing Chambers

Managing Temperature Fluctuations in Stability Testing Chambers Managing Temperature Fluctuations in Stability Testing Chambers Introduction: Stability testing is a critical component of the pharmaceutical development process, ensuring that drug products…